Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men

Background and Hypothesis: Lipoprotein(a) may play a part in the development of coronary heart disease. The purpose of this prospective study was to evaluate lipoprotein(a) as a predictor of major coronary events (fatal and nonfatal myocardial infarction and sudden death).

[1]  G. Lippi,et al.  Biochemical risk factors and patient's outcome: the case of lipoprotein(a). , 1999, Clinica chimica acta; international journal of clinical chemistry.

[2]  G. Dangas,et al.  Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. , 1998, Journal of the American College of Cardiology.

[3]  G. Dagenais,et al.  Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. , 1998, Journal of the American College of Cardiology.

[4]  F. Colombo,et al.  Lp(a) in hypertensive patients , 1998, Journal of Human Hypertension.

[5]  K. Bailey,et al.  Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. , 1997, Circulation.

[6]  B. Nordestgaard,et al.  In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  C. Gazzaruso,et al.  Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension , 1997, Journal of hypertension.

[8]  S. Kiechl,et al.  Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. , 1995, Stroke.

[9]  R. Prescott,et al.  Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis , 1995, The Lancet.

[10]  B. Fagerberg,et al.  The efficacy of multiple risk factor intervention in treated hypertensive men during long‐term follow up , 1994, Journal of internal medicine.

[11]  B. Fagerberg,et al.  Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[13]  S. Grundy,et al.  Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. , 1994, Archives of internal medicine.

[14]  J. Salonen,et al.  Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.

[15]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[16]  P. Allhoff,et al.  The Multifactor Primary Prevention Trial in Göteborg , 1991 .

[17]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[18]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[19]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.